Reuters on more drugmakers chasing the weight loss drug market
Reuters reports on a growing field of developers racing into obesity drugs as competition gets tighter.
Recap by typeshit. Full story at Reuters.
Read at Reuters
More peptides
-
A look at whether the munchies feel different for people on a GLP-1 
A look at whether the munchies feel different for people on a GLP-1
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
-
Philstar Life on celebrities and the weight loss drug Ozempic Philstar Life on celebrities and the weight loss drug Ozempic
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
-
Food and agribusiness expert says fibre is gaining ground with the GLP-1 trend 
Food and agribusiness expert says fibre is gaining ground with the GLP-1 trend
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
-
Experimental injection that makes fat cells self destruct shows early promise 
Experimental injection that makes fat cells self destruct shows early promise
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
-
Dr Pratik Shivhare on hair shedding linked to rapid weight loss on Ozempic 
peptides typeshitSafetyDr Pratik Shivhare on hair shedding linked to rapid weight loss on Ozempic
A short social post says fast weight loss on Ozempic may bring temporary hair shedding and that care can help, with few details beyond that.
-
News-Medical reviews what research shows on GLP-1 drugs for Parkinson's peptides typeshitResearchNews-Medical reviews what research shows on GLP-1 drugs for Parkinson's
GLP-1 drugs have shown neuroprotective effects in lab models, and the review looks at where human clinical evidence stands so far.